Similar Papers

Paper Title
Journal
Date
Author
ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.
Hisanaga Nomura ... Hiroyuki Daiko
Cancer Chemotherapy and Pharmacology | VOL. 86
Hisanaga Nomura, et. al.Hisanaga Nomura ... Hiroyuki Daiko
01 Aug 2020
Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients
Jing Gao ... Zhi Peng
Medical Oncology | VOL. 30
Jing Gao, et. al.Jing Gao ... Zhi Peng
20 Jun 2013
Advanced Stage Is a Risk for Severe Neutropenia in Breast Cancer Patients Undergoing Neoadjuvant Adriamycin/Cyclophosphamide/Docetaxel Chemotherapy.
Kazuki Moro ... Hiroshi Ichikawa
World journal of oncology | VOL. 13
Kazuki Moro, et. al.Kazuki Moro ... Hiroshi Ichikawa
01 Dec 2022
Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer.
Keisuke Shigeta ... Ryuichi Mizuno
International journal of clinical oncology | VOL. 20
Keisuke Shigeta, et. al.Keisuke Shigeta ... Ryuichi Mizuno
09 Sep 2014
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
89P Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Q Au ... V Chizhevsky
Annals of Oncology | VOL. 35
Q Au, et. al.Q Au ... V Chizhevsky
01 Dec 2024
276MO Epidemiology, treatment (tx) patterns, and clinical outcomes of patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) in Taiwan: A retrospective cohort study
C-T Wu ... L-N Chien
Annals of Oncology | VOL. 35
C-T Wu, et. al.C-T Wu ... L-N Chien
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.